b Background: Most clinical nursing research is limited to funded study periods. However, if clinical research data can be linked to population databases, researchers can study relationships between study measures and poststudy long-term outcomes. b Objectives: The objective was to describe the feasibility of linking research participant data to data from population databases in order to study long-term poststudy outcomes. As an exemplar, participants were linked from a completed oncology nursing research trial to outcomes data in two state population databases. b Methods: Participant data from a previously completed symptom management study were linked to the Utah Population Database and the Utah Emergency Department Database. The final data set contained demographic, cancer diagnosis and treatment and baseline data from the oncology study linked to poststudy long-term outcomes from the population databases. b Results: One hundred twenty-nine of 144 (89.6%) study were linked to their individual data in the population databases. Of those, 73% were linked to hospitalization records, 60% were linked to emergency department visit records, and 28% were identified as having died. b Discussion: Study participant data were successfully linked to population databases data to describe poststudy emergency department visit and hospitalization numbers and mortality. The results suggest that data linkage success can be improved if researchers include linkage and human subjects protection plans related to linkage in the initial study design. b
to population databases data to describe poststudy emergency department visit and hospitalization numbers and mortality. The results suggest that data linkage success can be improved if researchers include linkage and human subjects protection plans related to linkage in the initial study design. T he rapid advances in the early diagnosis and treatment of many diseases, including cancer, have resulted in decreased morbidity and mortality (Edwards et al., 2010) . Increasingly, researchers are focusing on how healthcare interventions impact long-term clinical and epidemiological outcomes, such as well-being, survival, and utilization of resources (Hawkins & Robison, 2006) . Unfortunately, the cost of following research participants over time is often prohibitive for all but the largest and best funded of studies. Therefore, most clinical research studies are limited in the length of follow-up time, as well as the long-term outcomes measured.
One possible way to follow research participants over long periods of time is to link their clinical research records to data in large population databases, clinical registries, and administrative databases. These large databases are often utilized for research; however, the type and quality of data vary greatly among them. Therefore, linkages among multiple databases are increasingly used to merge clinical data with administrative data to provide the power and depth of data needed to address clinical research questions extended through time (Dokholyan et al., 2009; Pasquali et al., 2013) . Linking these large databases to clinical research data could be used to study outcomes such as healthcare utilization and survival over longer periods of time without having to track individual study participants themselves. Doing so requires that critical issues related to privacy and protection of human research subjects be addressed. Furthermore, potential impediments to such linkages exist, including availability and accuracy of variables that could be used to correctly link an individual's record in one database to other databases and the technology available to perform complex data linkages.
The purpose of this research was to test the feasibility of linking clinical research data to large population databases in order to explore the relationships of clinical research findings with long-term outcomes. As an exemplar, we used data from a previously conducted clinical research study of a nursing intervention to improve cancer-related fatigue, which we linked to two different population databases maintained in Utah. The aim was to explore the relationship between baseline data at the time of cancer diagnosis and long-term outcomes, such as emergency department (ED) visits, hospitalizations, and survival. Here, the study (a) describes the data linkage process, (b) examines the feasibility of creating a linked data set to explore poststudy outcomes, and (c) provides recommendations for researchers designing clinical research studies who are considering long-term plans for linking study data to population databases. (An extensive substantive report of findings from the linkage of our clinical research data with poststudy outcomes is beyond the scope of this article.)
Methods
This feasibility study linked participants from an intervention study to improve cancer-related fatigue conducted a decade ago to the Utah Population Database (UPDB) and the state ED database.
Databases
Study Database Data from the Energy Conservation and Activity Management (ECAM) for patients with cancer-related fatigue trial were used as the exemplar. The ECAM trial was a multicenter, multistate study funded by the National Institutes of Health (R01 NU04573; Barsevick, PI) that tested a nursing intervention focused on helping patients to conserve energy as a strategy for managing fatigue during cancer treatment. The main findings of this study have been reported elsewhere (Barsevick, Dudley, & Beck, 2006; Barsevick et al., 2004) . Participants were enrolled in the study between September 1999 and October 2001 at the Huntsman Cancer Institute in Salt Lake City, UT and Fox Chase Cancer Center in Philadelphia, PA. All patients were initiating chemotherapy, radiation therapy, or combination therapy. The data set for this project of 151 participants enrolled at Huntsman Cancer Institute included demographic (including age at enrollment) and clinical information but did not contain names or date of birth. The original study also retained consent forms with handwritten signatures and dates and a separate file linking study ID to medical record numbers in the oncology clinic or radiation therapy department.
UPDB The UPDB is a research resource at the University of Utah containing Utah population data, including vital statistics (e.g., birth, marriage, and death certificates), cancer registry data from both Utah and Idaho, and driver's license data. It also includes claims data from statewide inpatient hospital discharge records as well as ambulatory surgery records from hospital outpatient departments and ambulatory surgery centers (Utah Population Database, n.d.). The UPDB contains a master subject index that allows for cross linkage with healthcare administrative records of all patient encounters maintained in electronic data warehouses (DuVall, Kerber, & Thomas, 2010) .
Access to the UPDB is governed by the Utah Resource for Genetic and Epidemiologic Research (RGE), which contracts with UPDB data contributors, such as hospital systems and the Department of Health, sets conditions for data use and reviews requests to access UPDB data. Personal information can be used by UPDB staff to match individuals from two or more datasets and then removed from the final linked data set provided to researchers (Wylie & Mineau, 2003) .
For this study, the ECAM participant data were linked to the UPDB using the best identifying information available from all sources. Three databases contained within the UPDB primarily provided data for the study. The Utah Cancer Registry contains statewide information from individuals diagnosed with cancer since 1966. The vital records death certificates database contains cause of death information. The hospital discharge database contains statewide populationbased information about hospitalizations in Utah. 
Human Subjects Research Protection
Because linking ECAM participant data to other databases was not included in the original ECAM study design, there was concern about confidentiality and privacy issues. In addition, the UPDB and the EDDB are under the oversight of two different committees. Therefore, work was done in tandem with three oversight committeesVthe University of Utah IRB, the RGE, and the Utah Department of Health IRBVto ensure that research participant personal health information was protected and that regulations for utilizing UPDB and EDDB records in research were followed.
The University of Utah IRB reviews all research projects that involve humans to ensure that they comply with the university policy and local, state, and federal laws and regulations regarding research. The University of Utah IRB approval requires RGE approval for use of UPDB data. The RGE governs access to UPDB data and research and works in tandem with the University of Utah IRB to ensure that human subjects data are protected. Waivers of consent and authorization were requested from the University of Utah IRB, which detailed how data identifiers would be protected. A component of RGE approval is review of the research by the Health Data Committee, a Department of Health committee established under Utah Health Code (x26Y33a) with oversight of the use and sharing of healthcare data collected by the Department of Health. Approval to access EDDB records was obtained from the Utah Department of Health IRB, which promotes ethical research and the protection of confidentiality and privacy of participants.
Once RGE and Utah Department of Health IRB approvals were obtained, the University of Utah IRB approved the study as a minimal risk study because study investigators never had access to identifying information other than what they possessed in the original ECAM study data set. Personal health information contained within the UPDB and EDDB that was used to identify and link records was only available to database administrators. After the record linkages were complete, all identifying information was removed prior to returning the linked data to the study investigators. This manuscript was submitted to the directors of the Health Data Center (Department of Health), the RGE, and the Utah Cancer Registry prior to submission for publication.
Data Linkage
The ECAM study data set and consent forms were used to generate a data file for the University of Utah Data Warehouse, which maintains medical records of patients treated within the University of Utah Health Care system. Data warehouse administrators matched medical record numbers provided by the ECAM data set to two different patient databases that were in use at the time of the original study. Records with medical record number matches were confirmed using gender and estimated year of birth and then forwarded to UPDB administrators for linkage to the UPDB datasets used for this study. Records without medical record number matches were manually linked to the UPDB using the other linkage variables.
Once the UPDB linkage was complete, the following information from the linked records was sent to the Intermountain Injury Control Research Center for linkage to EDDB records: names, birth dates, study recruitment dates, diagnosis dates, death dates, and zip codes. Probabilistic linkage using LinkSolv record linkage software (Strategic Matching, Inc., Morrisonville, NY) was used to link UPDB records to all EDDB records for visits after the date of cancer diagnosis. Probabilistic linkage is a method that links computerized records from two or more disparate data sources by comparing common linkage variables shared by each to make a judgment that records refer to the same person or event within the different datasets (Edelman, Cook, & Saffle, 2009; Lee et al., 2006) . Pairs of UPDB and ED records that had a 90% or greater probability of being a true match were linked. The final study data set, which was a result of the linkage of the ECAM, UPDB, and EDDB databases, contained the information shown in Table 1 .
Poststudy Outcomes
Mortality An ECAM participant was considered deceased if there was a Utah vital records death record, Social Security death index record, or death date on a Utah Cancer Registry record for that individual between time of study enrollment and December 31, 2010. Health Care Utilization The number of ED visits and hospitalizations were determined by the number of individual visits a participant linked to in the EDDB or in the hospital discharge database contained within the UPDB between the time of study enrollment and December 31, 2010.
Data Analysis
Data for this study were analyzed using the Statistical Package for the Social Sciences for Windows (Version 19.0; SPSS Inc., Chicago, IL). Descriptive statistics (means, standard deviation, and percentages) were used to describe demographics of the study sample and long-term outcomes (mortality and healthcare utilization, including ED visits and hospitalizations).
Results

Data Linkage
A schematic of the data linkage process is shown in Figure 1 . There were ECAM data for 151 participants; however, seven participants either dropped out of the study or had incomplete data. Therefore, the results of the linkage of 144 participants to the UPDB and EDDB using an iterative process are reported. In the first step, 65 of 144 (45.1 %) ECAM study patients were matched to records in the Data Warehouse and assigned distribution numbers that link Data Warehouse records to the UPDB. In 10 potential cases, the Data Warehouse provided additional information that allowed matching these 10 study records with the UPDB. Now, 75 of 144 (52.1%), with names, were linked to UPDB records.
Then, a second strategy was tried to improve record matches. Very few ECAM records contained names (15/144), but the ECAM consent forms had participant signatures that were deciphered as best possible. Deciphered names were matched to names of individuals in the UPDB who had a cancer record with a diagnosis date in proximity to the study consent recruitment date and clerically reviewed. This liberal matching resulted in only 25 of 144 (17.4%) of ECAM participants who were not linked to either the ECAM data or the UPDB. In order to confirm positive matches, the UPDB administrator hand-matched ECAM consent form recruitment dates to the ECAM database, using other linkage variables, q such as date of enrollment, gender, age, and cancer diagnosis to confirm a match. As a result, 129 of 144 ECAM participants were linked to the UPDB for a final linkage yield of 89.6%. All matches contained Utah Cancer Registry records, 94 (73%) linked to at least one hospital discharge record, and 31 (24%) linked to death certificate data.
The next step in the linkage process was to connect the 129 participants matched to UPDB records to the EDDB, which contains information on ED visits that do not result in hospitalization. Because the EDDB is not maintained within the UPDB and involves different database administrators, identifying information (name, date of birth, Utah Cancer Registry dates of diagnosis date, and ECAM recruitment dates) of ECAM participants was used to link EDDB data.
Sample Characteristics
Demographics of the 129 ECAM participants linked to the UPDB and/or EDDB are shown in Table 2 . Participants were predominantly White (94.6%) and female (87.6%). A vast majority were diagnosed with breast cancer (76.0%) and undergoing radiation (50.4%) or chemotherapy (45.0%). Poststudy Outcomes Sixty percent of participants had at least one ED visit (M = 1.72, Mdn = 1.00, range = 0j27 visits); 49% of those who had ED visits had more than one visit (Table 2) . Most participants (72.9%) were admitted to a Utah hospital at least once (M = 2.16, range = 0j11 visits); 67% of participants who were admitted to the hospital had more than one hospitalization. As of December 31, 2010, 36 of 129 (27.9%) ECAM participants were known to be deceased; 31 participants had death records, and another 5 participants were documented as deceased in the Utah Cancer Registry datasets contained within the UPDB.
Discussion
Clinical investigations in nursing are often time-limited and focused on a specific phase of diagnosis or treatment. Longitudinal studies are expensive, and study attrition over time can compromise data integrity. Thus, studies that extend beyond a brief clinical trial phase usually require large numbers of participants and assurance of continued funding. Population databases can include local, state, and national healthcare utilization and vital records databases, as well as hospital and administrative databases and disease registries that contain health outcomes data. These databases can provide researchers with clinical research study participant information on a range of healthcare utilization and long-term outcomes at different time points after a study has ended, saving research time and costs, and reducing participant burden (Moriarty et al., 1999) . As illustrated, successful linking of clinical research data to population databases depends on availability and quality of both the clinical research and population database data, the participant identifiers available, and the variables shared between databases (Moriarty et al., 1999) . All these factors can affect the validity of findings based on the linked data.
In this study, feasibility of linking clinical research data to population databases was enhanced by an established record of collaborations between health sciences researchers at our university and the Utah Department of Health, which maintains a number of state population databases (Edelman et al., 2009 ). The University of Utah is the home to the UPDB, one of the world's richest sources of in-depth information on more than 7.2 million individuals that can be used to support research on genetics, epidemiology, demography, and public health (Wylie & Mineau, 2003) . The UPDB holds records from a number of contributors, including the Utah Department of Health (births, deaths, marriages/divorces, hospitalizations, and ambulatory surgery), family history records, driver's licenses, and voter registration records (' 'Data,'' 2013) . Researchers have utilized UPDB data retrospectively to identify individuals with different cancer phenotypes and genotypes (Albright, Teerlink, Werner, & Cannon-Albright, 2012; Chow et al., 2009; Lin et al., 2011; Mueller et al., 2009) . The UPDB has also been used to link research subjects to relatives with data in the UPDB to study the effects of BRCA1/2 mutations on female fertility (Smith, Hanson, Mineau, & Buys, 2012) . UPDB data have recently been linked to data from a completed population-based autism prevalence study in order to examine mortality and causes of death (Bilder et al., 2013) ; however, unlike the feasibility study we report here the primary research study data included consistent identifying information.
The results of this study show the feasibility of linking completed oncology research participant data to large population databases to answer questions about long-term outcomes. Almost 90% of site data from a multicenter oncology study (ECAM) completed a decade ago were linked to the UPDB and the EDDB. However, the lack of consistent identifying information about the research participants required manual record matching, which is difficult and time-consuming. Had the data set of ECAM participants been large, this method would not have been feasible.
The site for this feasibility study is a regional cancer center and treats patients from a multistate area. Of the 129 ECAM participants linked to the UPDB and EDDB, 13 (10%) were residents of a neighboring state. Because the UPDB and Utah EDDB only include information on individuals who were treated at Utah hospitals, there was no information on ED visits and hospitalizations of participants when they occurred outside of Utah, which may have resulted in an under reporting of ED visits and hospitalizations in this study. Conversely, the Utah Cancer Registry does collect death certificate data from other states, so data about mortality events were not impacted by whether the death occurred in Utah.
By linking data from the ECAM oncology study to databases within the UPDB and the EDDB, it was possible to describe the number of ED visits, hospitalizations, and deaths experienced by study participants during the time following completion of the study. Poststudy long-term follow-up of research participants can provide important information on survivorship, quality of life, general health, and healthcare utilization. Unless a study has a plan to engage participants longterm, follow-up can be difficult and expensive. Linking participants to available population databases at different points in time can be an affordable way to acquire long-term outcome data.
This exemplar indicates that linking clinical research data to population databases in order to study long-term outcomes, after study closure is feasible. Large databases, such as administrative, state, and other patient or disease-oriented databases, may contain a plethora of information that could be used to study research participants longitudinally (Magee, Lee, Giuliano, & Munro, 2006) . Moriarty et al. (1999) identified a number of advantages to using large national databases for research of families, which can be generalized to most studies. These include the potential savings in time, costs and resources, decreased subject burden, and the inclusion of more variables (Moriarty et al., 1999) . As discussed above, database linkages can be compromised by data availability and quality, which can contribute to bias and may impact the validity of the findings (Moriarty et al., 1999) .
Almost 90% of site data were linked from a multicenter oncology study.Recommendations Recruitment to clinical studies is costly. Poststudy follow-up of participants should be considered and facilitated to leverage the value of project data. It is recommended that researchers incorporate anticipated data linkage plans when designing clinical studies rather than doing so retrospectively when the study has been completed. In doing so, researchers should take the following into consideration:
Always consider human subjects research and ethical issues. Be familiar with and incorporate your IRB's guidelines and requirements of other oversight committees associated with the databases into your study design. For example, if you know which databases you may want to link study participant data to in the future, permission to do so should be included in the study consent form. Recognize that working with multiple oversight committees takes considerable time and effort and involve the committees early in the research design process. In this exemplar, approval was received from three different oversight committees. The process went smoothly because key stakeholders were included early in the conceptualization and design of the data linkage process.
Retain allowable research participant identifying information in a secure fashion. This study demonstrated the need to keep identifying information in a separate file, but linked to the clinical research data set with a unique study ID. Some institutions might require that this data be securely retained by an institutional research administration group or a central repository for multicenter studies. If maintaining personal identifying information is not possible, consider the use of indirect patient identifiers such as birthdates, gender, and admission and discharge dates that could be used to link research data to other databases when allowable. Indirect identifiers have been used to successfully link clinical registry data with administrative databases (Pasquali et al., 2010) .
Know what personal identifying information is sufficient to provide the best linkage yield. Consider what identifying numbers are most likely to be retained over time in other databases. When allowable, full name, gender, and birth date are key linking variables. Consent forms should have the signature and the name printed underneath. Additional information such as residential address, medical record numbers, and Social Security numbers can be helpful in confirming potential data links when participants provide them and their use is approved as part of the linkage process.
Identify potential long-term outcomes in a study. When designing a study, identify potential long-term outcomes that may be of interest in the future, what databases might house those outcome variables, and if the variables are congruent with the study's conceptual framework (Magee et al., 2006) . Meeting with database administrators at this stage to discuss the administrative guidelines for accessing the data will ensure ease of linkage in the future.
Conclusions
Studying long-term clinical research outcomes can be complicated by the difficulty and expense of following research participants over time. In this article, the feasibility of using probabilistic linkage to join a small clinical research database with large population databases to explore the relationships of clinical research findings with poststudy outcomes was shown. Because the linkage to population databases was conducted many years after the clinical study was completed and identifying information had been purged or was inadequate, the resulting linkage process was difficult. Therefore, researchers should consider a number of issues when planning to use population databases to study long-term health outcomes. Most importantly, including poststudy linkage plans in the initial study design will simplify the linkage process and improve the linkage yield. Including a linkage plan in the original study design creates the opportunity to obtain explicit consent from participants to use specific data items for linkage with population databases, which can support consideration of the linkage project by committees charged with oversight and approval. In addition, it is important to establish relationships with database administrators, understand the responsibilities of database administrators, and archive clinical research data. Protection of participant confidentiality is paramount at every step of the process. With planning, population databases can be a rich and cost-effective source of data on the long-term outcomes of participants in clinical research studies. q Accepted for publication August 12, 2013.
